Stockscreener 앱 받기
21.52
2.75%
0.575
시간 외 거래:
21.73
0.215
+1.00%
Anbio Biotechnology 주식(NNNN)의 최신 뉴스
Anbio Biotechnology to Participate in KeyBanc Capital Markets Healthcare Forum on March 17, 2026 - geneonline.com
Anbio Biotechnology to Participate in KeyBanc Capital Markets Healthcare Forum - The Manila Times
Aktis Oncology (AKTS) Stock Analysis Report | Financials & Insights - Benzinga Japan
Oncocyte (NASDAQ:IMDX) versus Anbio Biotechnology (NASDAQ:NNNN) Head-To-Head Review - Defense World
Anbio Biotechnology and Oncocyte Compared in Financial Analysis - National Today
Anbio Biotechnology falls -5.8% - MSN
Head-To-Head Analysis: Oncocyte (NASDAQ:IMDX) & Anbio Biotechnology (NASDAQ:NNNN) - Defense World
Financial Analysis: Oncocyte (NASDAQ:IMDX) and Anbio Biotechnology (NASDAQ:NNNN) - Defense World
Anbio Biotechnology Stock Quote, Share Price, News and Analysis - Longbridge
Head to Head Contrast: Oncocyte (NASDAQ:IMDX) & Anbio Biotechnology (NASDAQ:NNNN) - Defense World
Anbio Biotechnology (NASDAQ:NNNN) vs. Oncocyte (NASDAQ:IMDX) Critical Comparison - Defense World
TechTarget (TTGT) to Release Earnings on Wednesday - Defense World
Anbio Biotechnology: Improved Margins, Still Priced For Growth That Isn't Showing Up - Seeking Alpha
NNNN Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Anbio Biotechnology Prioritizes Profitability Over Sales Volume - National Today
Oncocyte (NASDAQ:IMDX) versus Anbio Biotechnology (NASDAQ:NNNN) Head to Head Contrast - Defense World
NNNN Technical Analysis & Stock Price Forecast - Intellectia AI
Anbio Biotechnology Outperforms Oncocyte in Financial Metrics - National Today
Anbio Biotechnology (NNNN) Stock Analysis: Navigating Volatility in the Medical Instruments Sector - DirectorsTalk Interviews
Critical Comparison: Oncocyte (NASDAQ:IMDX) vs. Anbio Biotechnology (NASDAQ:NNNN) - Defense World
Celestica Inc. (TSE:CLS) Receives Average Recommendation of “Strong Buy” from Analysts - Defense World
Comparing Anbio Biotechnology (NASDAQ:NNNN) & Oncocyte (NASDAQ:IMDX) - Defense World
Financial Contrast: Oncocyte and Anbio Biotechnology - National Today
Head-To-Head Survey: Oncocyte (NASDAQ:IMDX) and Anbio Biotechnology (NASDAQ:NNNN) - Defense World
Reviewing Anbio Biotechnology (NASDAQ:NNNN) and Oncocyte (NASDAQ:IMDX) - Defense World
Diane Lazzaris Sells 2,747 Shares of WESCO International (NYSE:WCC) Stock - Defense World
Anbio Biotechnology and Oncocyte Compared: Which Stock Reigns Supreme? - National Today
Anbio Biotechnology (NNNN) Stock Analysis: What Investors Should Know About This German IVD Innovator - DirectorsTalk Interviews
Anbio Biotechnology prices $8M IPO at $5 per share - MSN
Oncocyte (NASDAQ:IMDX) vs. Anbio Biotechnology (NASDAQ:NNNN) Critical Comparison - Defense World
Anbio Biotechnology Replaces Auditor to Safeguard 2025 Reporting Timeline - TipRanks
Anbio Biotechnology (NNNN) names GGF CPA LTD as new independent auditor - Stock Titan
Head-To-Head Comparison: Oncocyte (NASDAQ:IMDX) and Anbio Biotechnology (NASDAQ:NNNN) - Defense World
IPO window reopens, med-tech class of 2025 gains 26% - bioworld.com
Head to Head Analysis: Oncocyte (NASDAQ:IMDX) & Anbio Biotechnology (NASDAQ:NNNN) - Defense World
COREwafer Industries Inc. (OTCMKTS:AHIX) Short Interest Up 126.9% in January - Defense World
GRAIL (GRAL) Projected to Post Earnings on Thursday - Defense World
Anbio Biotechnology (NASDAQ:NNNN) Stock Price Up 8.4%Should You Buy? - MarketBeat
Contrasting Oncocyte (NASDAQ:IMDX) & Anbio Biotechnology (NASDAQ:NNNN) - Defense World
Financial Survey: Oncocyte (NASDAQ:IMDX) and Anbio Biotechnology (NASDAQ:NNNN) - Defense World
Financial Comparison: Oncocyte (NASDAQ:IMDX) and Anbio Biotechnology (NASDAQ:NNNN) - Defense World
Anbio Biotechnology and Oncocyte: A Financial Review - National Today
Critical Analysis: Oncocyte (NASDAQ:IMDX) versus Anbio Biotechnology (NASDAQ:NNNN) - Defense World
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
Why Anbio Biotechnology Class A Shares Took Off - TipRanks
12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga
Anbio Biotechnology Class A Shares Surge After Volatility Pause - TipRanks
Disney, Micron Tech among market cap stock movers on Monday - Investing.com
Why Anbio Biotechnology Class A Shares Are Surging - TipRanks
InvestingPro’s overvalued warning saved investors from 54% Anbio Bio crash By Investing.com - Investing.com South Africa
Anbio Biotechnology (NNNN) Stock Trends and Sentiment 2026 - MarketBeat
Intel, Oracle among market cap stock movers on Monday By Investing.com - Investing.com Nigeria
Anbio Biotechnology Strengthens Board Oversight With Appointment of Michael Zhang as Audit Committee Chair - TipRanks
Anbio Biotechnology Announces Board and Committee Changes, Effective January 21, 2026 - marketscreener.com
Anbio Biotechnology (NNNN) Stock Analysis: A Rollercoaster Year With Growth Potential - DirectorsTalk Interviews
NNNN Forecast — Price Prediction for 2026. Should I Buy NNNN? - Intellectia AI
Industries Limited Rebound Backed by Sentiment ShiftMACD Trading Signals & Technical + Fundamental = Smarter Investing - bollywoodhelpline.com
S&P 500 Futures Up in Premarket Trading; QXO, Mosaic Lag - Barron's
Anbio Biotechnology (NASDAQ:NNNN) Stock Is Going Strong But Fundamentals Look Uncertain: What Lies Ahead ? - simplywall.st
Anbio Biotechnology's (NASDAQ:NNNN) Financials Are Too Obscure To Link With Current Share Price Momentum: What's In Store For the Stock? - Yahoo Finance
0.06%
0.65%
자본화:
|
볼륨(24시간):